Literature DB >> 10211996

Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy.

G Abu-Jawdeh1, N Comella, Y Tomita, L F Brown, K Tognazzi, S Y Sokol, O Kocher.   

Abstract

By using the differential display technique to identify genes that are differentially expressed in human endometrial carcinoma compared with normal endometrium, we have cloned frpHE, a novel member of the secreted frizzled gene family. By in situ hybridization, we have determined that frpHE is expressed by mesenchymal cells but not by epithelial cells. The expression of frpHE is modulated during the endometrial cycle: it is expressed in the stroma of proliferative endometrium and not significantly detectable in secretory or menstrual endometrium, suggesting that frpHE is under hormonal regulation. In addition, the expression of frpHE mRNA is markedly up-regulated in the stroma of endometrial hyperplasia and carcinoma and in the stroma of in situ and infiltrating breast carcinomas. Injection of frpHE mRNA in Xenopus embryos inhibited the Wnt-8 mediated dorsal axis duplication. These results indicate that frpHE functions as a regulator of the Wnt-frizzled signaling pathway and is involved in endometrial physiology and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211996

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

1.  The endometrial response to chorionic gonadotropin is blunted in a baboon model of endometriosis.

Authors:  J R A Sherwin; J M Hastings; K S Jackson; P A Mavrogianis; A M Sharkey; A T Fazleabas
Journal:  Endocrinology       Date:  2010-07-28       Impact factor: 4.736

2.  Uterine sensing of the embryo.

Authors:  Daniel D Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

3.  Coding regions of INHBA, SFRP4 and HOXA10 are not implicated in familial endometriosis linked to chromosome 7p13-15.

Authors:  J Lin; L Zong; S H Kennedy; K T Zondervan
Journal:  Mol Hum Reprod       Date:  2011-05-16       Impact factor: 4.025

Review 4.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

Review 5.  Wnt signaling and mammary tumorigenesis.

Authors:  M J Smalley; T C Dale
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 6.  Wnt signalling in implantation, decidualisation and placental differentiation--review.

Authors:  S Sonderegger; J Pollheimer; M Knöfler
Journal:  Placenta       Date:  2010-08-15       Impact factor: 3.481

7.  Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.

Authors:  Shannon N Westin; Russell R Broaddus; Lei Deng; Adrienne McCampbell; Karen H Lu; Robin A Lacour; Michael R Milam; Diana L Urbauer; Peter Mueller; James H Pickar; David S Loose
Journal:  Cancer Biol Ther       Date:  2009-11-05       Impact factor: 4.742

8.  SFRP4 was overexpressed in colorectal carcinoma.

Authors:  Dan Huang; Bin Yu; Yun Deng; Weiqi Sheng; Zhilei Peng; Wenxin Qin; Xiang Du
Journal:  J Cancer Res Clin Oncol       Date:  2010-03       Impact factor: 4.553

9.  Increased expression of secreted frizzled-related protein 4 in polycystic kidneys.

Authors:  Daniel Romaker; Michael Puetz; Sven Teschner; Johannes Donauer; Marcel Geyer; Peter Gerke; Brigitta Rumberger; Bernd Dworniczak; Petra Pennekamp; Björn Buchholz; H P H Neumann; Rajiv Kumar; Joachim Gloy; Kai-Uwe Eckardt; Gerd Walz
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

10.  Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome.

Authors:  M Bicer; P Alarslan; A Guler; I Demir; B Aslanipour; M Calan
Journal:  J Endocrinol Invest       Date:  2019-09-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.